News release excerpt provided by Business Wire.
After completing a seed round of funding raising $1.2 million for its new technology which offers a non-invasive tool for the detection and localization of cardiovascular disease, startup Genetesis has chosen the Mason Tech Elevator as its new home where company founders will work to scale the business for clinical testing and commercialization.
“We have found the right partner for long-term growth and talent attraction in the City of Mason,” said Peeyush Shrivastava, CEO of Genetesis and junior in biomedical science at The Ohio State University. “This is truly a milestone for us, and we love being in the middle of the growing biotech corridor in Mason.”
Click here to read the complete release.
Originally published April 21, 2017.